Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 316 of 1,261
  1. US 11111494

    Compositions for modulating Ataxin 2 expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  2. US 11111478

    Methods of producing T memory stem cell populations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  3. US 11111375

    Compositions and methods for generating oligodendrocyte precursors

    The Regents of the University of California · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  4. US 11111335

    Method of preparing carboxylic acid functionalized polymers

    Nektar Therapeutics · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  5. US 11111309

    Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4

    Dyne Therapeutics, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  6. US 11111306

    IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  7. US 11111277

    Influenza vaccines

    The Regents of the University of California · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  8. US 11111272

    α4α7 peptide monomer and dimer antagonists

    Protagonist Therapeutics, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  9. US 11111270

    Inhibitor of apoptosis protein (IAP) antagonists

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  10. US 11111278

    Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

    The Board of Regents of the University of Texas System · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  11. US 11111235

    Compounds, compositions, and methods

    DENALI THERAPEUTICS INC. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  12. US 11110181

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  13. US 11111214

    Kappa opioid agonists and uses thereof

    Nektar Therapeutics · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  14. US 11110183

    Method of delivering genes and drugs to a posterior segment of an eye

    United States Government as represented by the Department of Veterans Affairs · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  15. US 11110174

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  16. US 11110152

    Compositions and methods for treating and preventing lung disease

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  17. US 11110150

    Complexes of IL-15 and IL-15Ralpha and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  18. US 11110173

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  19. US 11110154

    Methods and compositions for treating Huntington's Disease

    Sangamo Therapeutics, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  20. US 11110134

    Direct-fed microbials

    MICROBIAL DISCOVERY GROUP, LLC · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  21. US 11110139

    Application of anthocyanin extract in preparing pharmaceutical composition for preventing and treating cardiac toxicity induced by anthracyclines and pharmaceutical composition

    Northwest Institute of Plateau Biology, Chinese Academy of Sciences · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  22. US 11110106

    Sting agonists for treating bladder cancer and solid tumors

    VENENUM BIODESIGN, LLC · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  23. US 11110129

    Method for treating multiple sclerosis

    China Medical University · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  24. US 11110103

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.